These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Synthesis and evaluation of analgesic, anti-inflammatory and ulcerogenic activities of some triazolo- and 2-pyrazolyl-pyrido[2,3-d]-pyrimidines. Hafez HN; Abbas HA; El-Gazzar AR Acta Pharm; 2008 Dec; 58(4):359-78. PubMed ID: 19103572 [TBL] [Abstract][Full Text] [Related]
31. The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognition. Cheong SL; Dolzhenko A; Kachler S; Paoletta S; Federico S; Cacciari B; Dolzhenko A; Klotz KN; Moro S; Spalluto G; Pastorin G J Med Chem; 2010 Apr; 53(8):3361-75. PubMed ID: 20307065 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and antibacterial activity of fused 1, 2, 4-triazolo[4, 3-a]quinoxaline and oxopyrimido[2', 1':5, 1]-1, 2, 4-triazolo[4, 3-a]quinoxaline derivatives. Nasr MN Arch Pharm (Weinheim); 2002 Aug; 335(8):389-94. PubMed ID: 12397623 [TBL] [Abstract][Full Text] [Related]
33. [Synthesis of pyrrolo(2,3-d)pyrimidines (author's transl)]. Roth HJ; Eger K Arch Pharm (Weinheim); 1975 Apr; 308(4):252-8. PubMed ID: 1130967 [No Abstract] [Full Text] [Related]
34. [1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists: Modifications at the 8 position to reach selectivity towards A Federico S; Margiotta E; Salmaso V; Pastorin G; Kachler S; Klotz KN; Moro S; Spalluto G Eur J Med Chem; 2018 Sep; 157():837-851. PubMed ID: 30144700 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and antiallergy activity of [1,3,4]thiadiazolo[3,2-a]-1,2,3-triazolo[4,5-d]pyrimidin-9(3H)-one derivatives. II. 6-Alkyl- and 6-cycloalkylalkyl derivatives. Yokohama S; Miwa T; Aibara S; Fujiwara H; Matsumoto H; Nakayama K; Iwamoto T; Mori M; Moroi R; Tsukada W Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2391-8. PubMed ID: 1446361 [TBL] [Abstract][Full Text] [Related]
36. Synthesis of new functionalized 3-substituted [1,2,4]triazolo [4,3-a]pyrimidine derivatives: potential antihypertensive agents. Ali KA; Ragab EA; Farghaly TA; Abdalla MM Acta Pol Pharm; 2011; 68(2):237-47. PubMed ID: 21485297 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and in vitro activity of novel 1,2,4-triazolo[4,3-a]pyrimidine oxazolidinone antibacterial agents. Part II. Khera MK; Cliffe IA; Prakash O Bioorg Med Chem Lett; 2011 Sep; 21(18):5266-9. PubMed ID: 21835618 [TBL] [Abstract][Full Text] [Related]
38. Synthesis, antifungal activity and CoMFA analysis of novel 1,2,4-triazolo[1,5-a]pyrimidine derivatives. Chen Q; Zhu XL; Jiang LL; Liu ZM; Yang GF Eur J Med Chem; 2008 Mar; 43(3):595-603. PubMed ID: 17618711 [TBL] [Abstract][Full Text] [Related]
39. Characterization and preliminary use of 1-, 2- and 3-methyl-5-phenyl-7-chloro-1,2,3-triazolo[4,5-d]pyrimidine as reaction intermediates. Biagi G; Giorgi I; Livi O; Scartoni V; Barili PL Farmaco; 2003 Aug; 58(8):551-6. PubMed ID: 12875884 [TBL] [Abstract][Full Text] [Related]
40. New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol. Lauria A; Abbate I; Patella C; Martorana A; Dattolo G; Almerico AM Eur J Med Chem; 2013 Apr; 62():416-24. PubMed ID: 23395722 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]